McKesson, Stockholders Reach $175M Deal In Opioid Suit
Stockholders suing pharmaceutical distributor McKesson Corp. told a Delaware Chancery Court judge Thursday they had reached a $175 million settlement to resolve claims the company's board failed in its oversight of...To view the full article, register now.
Already a subscriber? Click here to view full article